ESSEX INVESTMENT MANAGEMENT CO LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 135 filers reported holding ENDOLOGIX INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2016$661,000
+54.8%
51,630
+50.7%
0.11%
+49.3%
Q2 2016$427,000
-36.9%
34,250
-13.6%
0.07%
-25.3%
Q1 2015$677,000
+118.4%
39,635
+95.2%
0.10%
+111.1%
Q4 2014$310,000
+44.2%
20,3030.0%0.04%
+36.4%
Q3 2014$215,000
-83.5%
20,303
-76.3%
0.03%
-82.8%
Q2 2014$1,303,000
+2.2%
85,652
-13.6%
0.19%
+3.2%
Q1 2014$1,275,000
-22.7%
99,078
+4.8%
0.19%
-20.2%
Q4 2013$1,649,000
+11.5%
94,552
+3.1%
0.23%
+4.0%
Q3 2013$1,479,000
+764.9%
91,665
+613.6%
0.22%
+646.7%
Q2 2013$171,00012,8450.03%
Other shareholders
ENDOLOGIX INC shareholders Q2 2013
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$49,653,0005.91%
Essex Woodlands Management, Inc. 1,257,468$21,220,0003.88%
PURA VIDA INVESTMENTS, LLC 205,100$2,515,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,347,113$28,776,0001.11%
First Light Asset Management, LLC 180,963$2,219,0001.10%
ArrowMark Colorado Holdings LLC 2,889,546$35,426,0000.97%
PALISADE CAPITAL MANAGEMENT, LP 2,149,949$26,358,0000.78%
Iguana Healthcare Management, LLC 150,000$1,839,0000.72%
CADIAN CAPITAL MANAGEMENT, LP 1,492,443$18,297,0000.66%
WASHINGTON CAPITAL MANAGEMENT, INC 85,882$1,053,0000.66%
View complete list of ENDOLOGIX INC shareholders